Environmental stress has shown to affect both the exposed individuals and the development of their offspring. Generally, it is thought that the stressed organism responds to stress by trying to adapt to it. This thesis investigates possible evolutionary consequences of cross-generational transmissions of stress, where the parent has been stressed but the offspring has not. In two studies we have exposed chicken parents of different breeds to an unpredictable circadian light rhythm, to investigate the influence of genetic background on the transmission of behaviour and patterns of genome-wide gene expression across generations. In Paper I, we can show that the domesticated chicken, by means of epigenetic factors, transmit their behaviours as well as their gene expression profiles to their offspring to a higher extent than their wild ancestor, the red junglefowl. Furthermore, in Paper II, even though the offspring never experienced the stress or had any contact with their stressed parents, they seemed to have adapted to it, which suggests that the parents might have prepared (or pre-adapted) them for living in the unpredictable environment. Additionally, eggs of stressed hens showed increased levels of estradiol that might have affected gene expression of specific immune genes, which were up-regulated in the offspring of stressed parents. It is possible that the traditional distinction between stress responses and evolutionary adaptation may be reevaluated, since our results indicate that they could be parts of the same evolutionary event.

<p> The age at which a juvenile female reaches sexual maturity can be modulated by a variety of environmental and social factors. Experiments described in this thesis were designed to enhance the current understanding of the relationships among three variables that influence the onset of sexual maturation in female mice (Mus musculus), including: [1] exposure to dietary phytoestrogens during development, [2] variations in prenatal androgens, and [3] the presence or absence of genetically-unrelated males after weaning. For the first time, age at onset of male-induced female puberty was investigated using non-invasive behavioural and fertility measures. Through enzyme immunoassay procedures, daily output of urinary creatinine, 17P-estradiol, and progesterone was profiled in developing females that were either isolated or exposed to adult males. Uterine and ovarian tissue was also measured in such females, and male exposure was observed to increase reproductive tissue mass and was influenced by prior androgen exposure in interaction with diet and male presence. Male-exposed females fed a diet containing phytoestrogens immediately became sexually receptive when housed directly with males, and they conceived earlier than females in other conditions. Females with longer anogenital distance, which reflects higher in utero androgen exposure, displayed more escape attempts and aggressive posturing in the direct presence of males, especially when they had been housed near males and fed the phytoestrogen-containing diet. Urinary 17P-estradiol was substantially reduced in females raised on the phytoestrogenfree diet. Urinary output of progesterone was not strongly influenced by diet. Maleexposed females ' output of progesterone and 17P-estradiol was more dynamic in comparison to that of isolated females. The size of this effect depended on diet, prior androgen exposure, and whether urinary steroid measures were adjusted by urinary creatinine. Urinary creatinine was elevated by the low phytoestrogen diet and reduced by male exposure. These data suggest that dietary phytoestrogens and in utero androgen exposure interact with presence or absence of males in determining the age at onset of sexual maturity in developing females. </p> <p> A final experiment was designed to examine two components of adult male urine, preputial gland emissions and unconjugated estrogens, that have been posited to act on females to advance reproductive maturation. Intact and preputialectomized males were compared in their output of urinary creatinine, 17~-estradiol, and testosterone, and in their influence on reproductive tissue in juvenile females. Lack of preputial glands did not hinder the capacity of males to induce uterine and ovarian growth in females. Male urinary creatinine was reduced by exposure to juvenile females. Creatinine-adjusted 17~estradiol and testosterone were greater in female-exposed males, regardless of whether the preputial glands were present. Based on these findings and those reported elsewhere, it is probable that male excreted urinary steroids are important in regulating reproductive changes in developing females exposed to males. </p> / Thesis / Doctor of Philosophy (PhD)

Clinical and experimental studies have shown that estradiol (E2) can enhance protection against sexually transmitted infections such as HSV-2 and HIV-1. Antigen presenting cells (APCs) such as Dendritic cells (DCs) are critical for generating immune responses against these infections, and it is unclear whether unique factors present in the genital mucosa can influence immune responses by directly modulating the phenotype and function of local APCs. To address this, I hypothesized that sex hormones, such as E2 and innate factors in the local microenvironment can regulate the phenotype and function of vaginal APCs. The work summarized in this thesis addressed this central hypothesis. In the first section of the thesis, I examined whether vaginal APCs were distinct in their phenotype and function compared to those in other mucosal tissues or spleen. The results show that the vagina was enriched in CD11c+ CD11b+ MHCII− DCs. Functionally, vaginal tissue cells (TC) and CD11c+ DCs were more potent inducers of Th17 responses in co-cultures with CD4+ T cells, compared to lung, small intestine or spleen APCs. E2 was critical for the conditioning of vaginal DCs to prime these Th17 responses through an IL-1-dependent pathway, indicating that sex hormones such as E2 can directly influence the function of vaginal APCs. In the next section, I determined whether other co-factors in the genital microenvironment such as microflora and innate lymphocytes could also influence vaginal APC functions. We found that while microflora was not essential, IL-17 produced by innate lymphocytes was critical for the induction of IL-1 from DCs, and consequently for potentiating Th17 responses. Finally, I attempted to develop an in vivo mouse model where the effect of E2 on vaginal APCs could be examined in the context of genital HSV-2 infection. I tested a 7-day injectable E2 and a 21-day E2 pellet delivery model, and found that both regimes had limitations for examining E2-effects on anti-viral responses. Yet, subsequent to the work done in this thesis, we were able to confirm our observations of E2-conditioned Th17 responses in vivo in an intranasal immunization model utilizing E2 pellet delivery, and thereby addressed the mechanism underlying enhanced anti-viral protection following E2-treatment. In conclusion, this is the first study to show the effect of E2 on genital tract APCs and their ability to prime Th17 responses. It provides future avenues to examine whether modulation of this microenvironment can help optimize vaccine-induced immune responses against STIs. On a more fundamental level, it highlights the need to consider the inherent distinctions in APC populations among different mucosal tissues. / Dissertation / Doctor of Philosophy (PhD)

No description available.

No description available.

Introdução: A síndrome antifosfolípide é uma doença autoimune caracterizada por eventos trombóticos e/ou obstétricos adversos associados à presença de anticorpos antifosfolípides. Considera-se síndrome antifosfolípide primária (SAFP) quando não há outra doença autoimune ou inflamatória associada. Objetivos: Avaliar marcadores de reserva ovariana em mulheres com SAFP e a associação entre estes marcadores e dados clínicos, laboratoriais e anticorpo anti-corpo lúteo (anti-CoL). Métodos: Realizou-se estudo transversal em 18 pacientes com SAFP e 24 controles. A reserva ovariana foi avaliada na fase folicular precoce através das dosagens de hormônio folículo estimulante (FSH), hormônio luteinizante (LH), estradiol e hormônio anti-Mülleriano (HAM), pela técnica de ELISA, e contagem ultrassonográfica de folículos antrais (CFA). O anti-CoL foi avaliado através de immunoblot. Todas as análises foram realizadas após suspensão de contraceptivo hormonal por, no mínimo, 6 meses e retorno das menstruações. O teste t foi utilizado para comparar médias ± desvio padrão e o teste de Mann-Whitney, para comparar medianas (variação). O teste exato de Fisher foi utilizado para comparar diferenças entre variáveis categóricas. Adotou-se nível de significância de 5% (p<0,05). Resultados: A média da idade foi similar em pacientes com SAFP e controles (33,0 ± 5,0 vs. 30,4 ± 7,0 anos, p=0,19). Houve maior frequência de CFA baixa (<=10) (56% vs. 22%, p=0,04) e muito baixa (<=5) (37% vs. 9%, p=0,04) em pacientes com SAFP quando comparadas aos controles. Em relação ao HAM, observou-se tendência de maior frequência de concentração sérica reduzida (<1,0 ng/mL), baixa (<0,5 ng/mL) e muito baixa (<0,2 ng/mL) em pacientes com SAFP (p=0,08; p=0,07 and p=0,07; respectivamente). As concetrações séricas de FSH, LH e estradiol foram semelhantes em pacientes e controles (p>0,05). Não houve associação entre baixa reserva ovariana e tipos específicos de anticorpos antifosfolípides. A presença do anti-CoL foi observada apenas em pacientes com SAFP (11% vs. 0%, p=0,177) e não foi relacionada a parâmetros de reserva ovariana. Conclusões: Pacientes com SAFP apresentaram reserva ovariana diminuída, com prevalência maior do que 50%, o que reforça o aconselhamento reprodutivo e planejamento familiar / Introduction: Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and/or pregnancy morbidity associated with antiphospholipid antibodies. Primary APS (PAPS) is diagnosed when no other autoimmune or inflammatory diseases are present. Objective: to determine ovarian reserve in PAPS women and to evaluate the association between ovarian reserve tests and clinical and laboratorial parameters, and anti-corpus luteum antibody (anti-CoL). Methods: In this cross sectional study, 18 PAPS patients and 24 healthy women were evaluated at early follicular phase with measurement of follicle stimulating hormone (FSH), estradiol, and anti-Müllerian hormone (AMH), carried out by ELISA test, and sonographic antral follicle count (AFC). Serum measurement of anti-CoL was determined by immunoblot analysis. All analyses were performed after at least 6 months from the last intake of hormonal contraceptive and resumption of menstruation. Data were compared by t-test and Mann-Whitney test in continuous variables and by Fisher\'s exact test in categorical variables. The level of significance was set at 5% (p<0.05). Results: The mean age was comparable in PAPS and controls (33.0 ± 5.0 vs. 30.4 ± 7.0 years; p=0.19). Regarding ovarian reserve tests, the frequencies of low AFC (<= 10) (56% vs. 22%, p=0.04) and very low AFC (<= 5) (37% vs. 9%, p=0.04) were significantly higher in PAPS patients than controls. Trends of higher frequencies of reduced (<1.0 ng/mL), low (<0.5 ng/mL) and negligible (<0.2 ng/mL) AMH levels were found in PAPS patients (p=0.08; p=0.07 and p=0.07; respectively). FSH, LH and estradiol were similar in patients and controls. There was no association between low ovarian reserve and specific types of antiphospholipid antibodies. Anti-CoL was solely observed in PAPS patients (11% vs. 0%; p=0.177) and was not related to ovarian reserve tests. Conclusion: Women suffering from PAPS possessed reduced ovarian reserve, with prevalence greater than 50%, emphasizing fertility counseling and family planning

A perimenopausa é a fase da vida reprodutiva feminina caracterizada diversas alterações, inclusive cognitivas devido ao hipoestrogenismo. Através de estudo duplo-cego randomizado com 16 mulheres na perimenopausa deprimidas que receberam estradiol e 16 que receberam placebo analisou-se as alterações cognitivas da atenção, memória e linguagem; o efeito da reposição hormonal com estradiol e a correlação entre os sintomas depressivos e menopausais com as alterações destas funções. Os resultados mostraram: melhora do controle inibitório, memória imediata e tardia (verbal e visual) e da capacidade de nomeação nos dois grupos; melhora dos sintomas depressivos e menopausais para o grupo que recebeu reposição hormonal: e não correlação entre a melhora destes sintomas e a melhora das funções cognitivas / Perimenopause is the female reproductive life period characterized by several changes including cognitive impairments related to hypoestrogenism. In a randomized double-blind study 16 depressive perimenopaused women took estradiol, while another group of 16 depressive perimenopaused women took placebo. Cognitive alterations associated to attention, memory and language, and estradiol hormone replacement therapy effects were evaluated. In addition, correlations among symptoms of depression and menopause, and cognitive alterations were also analyzed. The results had shown, in both groups, an improvement in inhibitory mental control, in immediate and delayed (verbal and visual) memory, and in naming capacity. In the group that received hormone replacement therapy our findings revealed a weakening of depression and menopause symptoms, which had shown no correlation with cognitive functions

A ocorrência de fármacos residuais no meio ambiente pode levar a efeitos adversos, tanto em organismos aquáticos como em terrestres. Os fármacos, tanto humanos como de uso veterinário, são absorvidos pelo organismo e estão sujeitos a reações metabólicas e, uma quantidade significativa dessas substâncias, tanto a original como seus metabólitos, são excretadas. Por não serem facilmente biodegradáveis, terem propriedades farmacológicas danosas quando administrados indevidamente, através de água contaminada, é crescente a preocupação com o destino destes fármacos residuais, principalmente com relação à avaliação de risco ambiental. A ocorrência destes resíduos, principalmente em águas superficiais e sistemas de abastecimento, vem sendo objeto de estudos em diversos países, principalmente na Europa. Por isso, a detecção, a eliminação e a investigação do destino destes compostos estrógenos em ecossistemas aquáticos têm tido prioridade na química ambiental. Estes produtos são encontrados nos corpos d\'água em baixas concentrações, de \'mü\'g L-1 a \'eta\'g L-1 e, mesmo assim, podem afetar os organismos por meio da bioacumulação. Estudos toxicológicos relacionados a efeitos crônicos em organismos expostos, são escassos. O objetivo do projeto foi adaptar e validar a metodologia analítica, e monitorar a presença de resíduos de hormônios nas águas dos Rios Corumbataí e Piracicaba e amostras de água de abastecimento da cidade de Piracicaba, SP, Brasil. Foram coletadas amostras de água bruta dos Rios Piracicaba e Corumbataí e água de abastecimento residencial da cidade de Piracicaba, SP, no período de novembro de 2007 a abril de 2009. Dentre os hormônios estudados estão o 17\'alfa\'-etinilestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) e estriol (E3). O método foi baseado na extração em fase sólida (SPE) e cromatografia líquida de alta eficiência (HPLC-DAD) / The occurrence of drug residues in the environment may lead to adverse effects, both on land and aquatic organisms. The drugs, for human and veterinary use, are absorbed by the organism and are subjected to metabolic reactions and a significant amount of these substances, both the original and its metabolites are excreted. By being not easily biodegradable and by having harmful pharmacological properties when administered through contaminated water, there is a growing concern about the fate of these residual drugs, especially in respect to the assessment of environmental risks. The occurrence of these residues, especially in surface Waters and water supplies has been the subject of studies in several countries, mainly in Europe. Therefore, detection, investigation and disposal of the fate of these estrogens compounds in aquatic ecosystems have a high priority in the field of environmental chemistry. These products are found in water bodies in low concentrations, from \'mü\'g L-1 a \'eta\'g L-1 and can still affect the organisms due to bioaccumulation. Toxicological studies related to chronic effects in the exposed organisms are scarce. The goals of this project was to adapt and validate the analytical methodology, and monitor the presence of hormone residues in the Waters of the Corumbataí and Piracicaba rivers and samples of water supply from the city of Piracicaba, SP, Brazil. We collected samples of raw water from the rivers of Piracicaba and Corumbataí and residential water supply from the city of Piracicaba in the period November 2007 to April 2009. Among the hormones studied are the 17\'alfa\'-ethinylestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) and estriol (E3). The method is based on solid phase extraction (SPE) and high performance liquid chromatography (HPLC-DAD)

A ocorrência de fármacos residuais no meio ambiente pode levar a efeitos adversos, tanto em organismos aquáticos como em terrestres. Os fármacos, tanto humanos como de uso veterinário, são absorvidos pelo organismo e estão sujeitos a reações metabólicas e, uma quantidade significativa dessas substâncias, tanto a original como seus metabólitos, são excretadas. Por não serem facilmente biodegradáveis, terem propriedades farmacológicas danosas quando administrados indevidamente, através de água contaminada, é crescente a preocupação com o destino destes fármacos residuais, principalmente com relação à avaliação de risco ambiental. A ocorrência destes resíduos, principalmente em águas superficiais e sistemas de abastecimento, vem sendo objeto de estudos em diversos países, principalmente na Europa. Por isso, a detecção, a eliminação e a investigação do destino destes compostos estrógenos em ecossistemas aquáticos têm tido prioridade na química ambiental. Estes produtos são encontrados nos corpos d\'água em baixas concentrações, de \'mü\'g L-1 a \'eta\'g L-1 e, mesmo assim, podem afetar os organismos por meio da bioacumulação. Estudos toxicológicos relacionados a efeitos crônicos em organismos expostos, são escassos. O objetivo do projeto foi adaptar e validar a metodologia analítica, e monitorar a presença de resíduos de hormônios nas águas dos Rios Corumbataí e Piracicaba e amostras de água de abastecimento da cidade de Piracicaba, SP, Brasil. Foram coletadas amostras de água bruta dos Rios Piracicaba e Corumbataí e água de abastecimento residencial da cidade de Piracicaba, SP, no período de novembro de 2007 a abril de 2009. Dentre os hormônios estudados estão o 17\'alfa\'-etinilestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) e estriol (E3). O método foi baseado na extração em fase sólida (SPE) e cromatografia líquida de alta eficiência (HPLC-DAD) / The occurrence of drug residues in the environment may lead to adverse effects, both on land and aquatic organisms. The drugs, for human and veterinary use, are absorbed by the organism and are subjected to metabolic reactions and a significant amount of these substances, both the original and its metabolites are excreted. By being not easily biodegradable and by having harmful pharmacological properties when administered through contaminated water, there is a growing concern about the fate of these residual drugs, especially in respect to the assessment of environmental risks. The occurrence of these residues, especially in surface Waters and water supplies has been the subject of studies in several countries, mainly in Europe. Therefore, detection, investigation and disposal of the fate of these estrogens compounds in aquatic ecosystems have a high priority in the field of environmental chemistry. These products are found in water bodies in low concentrations, from \'mü\'g L-1 a \'eta\'g L-1 and can still affect the organisms due to bioaccumulation. Toxicological studies related to chronic effects in the exposed organisms are scarce. The goals of this project was to adapt and validate the analytical methodology, and monitor the presence of hormone residues in the Waters of the Corumbataí and Piracicaba rivers and samples of water supply from the city of Piracicaba, SP, Brazil. We collected samples of raw water from the rivers of Piracicaba and Corumbataí and residential water supply from the city of Piracicaba in the period November 2007 to April 2009. Among the hormones studied are the 17\'alfa\'-ethinylestradiol (17\'alfa\'-EE2), 17\'beta\'-estradiol (17\'beta\'-E2) and estriol (E3). The method is based on solid phase extraction (SPE) and high performance liquid chromatography (HPLC-DAD)

Introdução: A síndrome antifosfolípide é uma doença autoimune caracterizada por eventos trombóticos e/ou obstétricos adversos associados à presença de anticorpos antifosfolípides. Considera-se síndrome antifosfolípide primária (SAFP) quando não há outra doença autoimune ou inflamatória associada. Objetivos: Avaliar marcadores de reserva ovariana em mulheres com SAFP e a associação entre estes marcadores e dados clínicos, laboratoriais e anticorpo anti-corpo lúteo (anti-CoL). Métodos: Realizou-se estudo transversal em 18 pacientes com SAFP e 24 controles. A reserva ovariana foi avaliada na fase folicular precoce através das dosagens de hormônio folículo estimulante (FSH), hormônio luteinizante (LH), estradiol e hormônio anti-Mülleriano (HAM), pela técnica de ELISA, e contagem ultrassonográfica de folículos antrais (CFA). O anti-CoL foi avaliado através de immunoblot. Todas as análises foram realizadas após suspensão de contraceptivo hormonal por, no mínimo, 6 meses e retorno das menstruações. O teste t foi utilizado para comparar médias ± desvio padrão e o teste de Mann-Whitney, para comparar medianas (variação). O teste exato de Fisher foi utilizado para comparar diferenças entre variáveis categóricas. Adotou-se nível de significância de 5% (p<0,05). Resultados: A média da idade foi similar em pacientes com SAFP e controles (33,0 ± 5,0 vs. 30,4 ± 7,0 anos, p=0,19). Houve maior frequência de CFA baixa (<=10) (56% vs. 22%, p=0,04) e muito baixa (<=5) (37% vs. 9%, p=0,04) em pacientes com SAFP quando comparadas aos controles. Em relação ao HAM, observou-se tendência de maior frequência de concentração sérica reduzida (<1,0 ng/mL), baixa (<0,5 ng/mL) e muito baixa (<0,2 ng/mL) em pacientes com SAFP (p=0,08; p=0,07 and p=0,07; respectivamente). As concetrações séricas de FSH, LH e estradiol foram semelhantes em pacientes e controles (p>0,05). Não houve associação entre baixa reserva ovariana e tipos específicos de anticorpos antifosfolípides. A presença do anti-CoL foi observada apenas em pacientes com SAFP (11% vs. 0%, p=0,177) e não foi relacionada a parâmetros de reserva ovariana. Conclusões: Pacientes com SAFP apresentaram reserva ovariana diminuída, com prevalência maior do que 50%, o que reforça o aconselhamento reprodutivo e planejamento familiar / Introduction: Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and/or pregnancy morbidity associated with antiphospholipid antibodies. Primary APS (PAPS) is diagnosed when no other autoimmune or inflammatory diseases are present. Objective: to determine ovarian reserve in PAPS women and to evaluate the association between ovarian reserve tests and clinical and laboratorial parameters, and anti-corpus luteum antibody (anti-CoL). Methods: In this cross sectional study, 18 PAPS patients and 24 healthy women were evaluated at early follicular phase with measurement of follicle stimulating hormone (FSH), estradiol, and anti-Müllerian hormone (AMH), carried out by ELISA test, and sonographic antral follicle count (AFC). Serum measurement of anti-CoL was determined by immunoblot analysis. All analyses were performed after at least 6 months from the last intake of hormonal contraceptive and resumption of menstruation. Data were compared by t-test and Mann-Whitney test in continuous variables and by Fisher\'s exact test in categorical variables. The level of significance was set at 5% (p<0.05). Results: The mean age was comparable in PAPS and controls (33.0 ± 5.0 vs. 30.4 ± 7.0 years; p=0.19). Regarding ovarian reserve tests, the frequencies of low AFC (<= 10) (56% vs. 22%, p=0.04) and very low AFC (<= 5) (37% vs. 9%, p=0.04) were significantly higher in PAPS patients than controls. Trends of higher frequencies of reduced (<1.0 ng/mL), low (<0.5 ng/mL) and negligible (<0.2 ng/mL) AMH levels were found in PAPS patients (p=0.08; p=0.07 and p=0.07; respectively). FSH, LH and estradiol were similar in patients and controls. There was no association between low ovarian reserve and specific types of antiphospholipid antibodies. Anti-CoL was solely observed in PAPS patients (11% vs. 0%; p=0.177) and was not related to ovarian reserve tests. Conclusion: Women suffering from PAPS possessed reduced ovarian reserve, with prevalence greater than 50%, emphasizing fertility counseling and family planning